301584 建发致新
交易中 08-26 13:23:30
资讯
新帖
简况
建发致新：长城证券、国泰海通证券等多家机构于8月20日调研我司
证券之星 · 08-21
建发致新：长城证券、国泰海通证券等多家机构于8月20日调研我司
建发致新（301584）2026年中报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 08-18
建发致新（301584）2026年中报简析：营收净利润同比双双增长，盈利能力上升
建发致新2026年半年报：营收微增，高应收、行业低毛利风险待解
蓝鲸财经 · 08-17
建发致新2026年半年报：营收微增，高应收、行业低毛利风险待解
建发致新：公司无逾期担保的情形
证券日报 · 08-16
建发致新：公司无逾期担保的情形
图解建发致新中报：第二季度单季净利润同比下降5.72%
证券之星 · 08-16
图解建发致新中报：第二季度单季净利润同比下降5.72%
建发致新(301584)8月10日股东户数1.9万户，较上期增加9.63%
证券之星 · 08-16
建发致新(301584)8月10日股东户数1.9万户，较上期增加9.63%
建发致新(301584.SZ)：上半年净利润1.48亿元 同比增长7.98%
中金财经 · 08-16
建发致新(301584.SZ)：上半年净利润1.48亿元 同比增长7.98%
建发致新拟每10股派发现金股利1元
财中社 · 08-16
建发致新拟每10股派发现金股利1元
建发致新最新公告：2026年半年度净利润1.48亿元同比增长7.98%
证券之星 · 08-16
建发致新最新公告：2026年半年度净利润1.48亿元同比增长7.98%
建发致新：截止最近一次查询日2026年8月10日，公司股东数量为18,972名
证券之星 · 08-14
建发致新：截止最近一次查询日2026年8月10日，公司股东数量为18,972名
建发致新（301584）披露为下属子公司提供担保的进展公告，8月10日股价上涨2.52%
证券之星 · 08-10
建发致新（301584）披露为下属子公司提供担保的进展公告，8月10日股价上涨2.52%
股市必读：建发致新（301584）新发布《2026年第三次临时股东会决议公告》
证券之星 · 07-31
股市必读：建发致新（301584）新发布《2026年第三次临时股东会决议公告》
股市必读：建发致新（301584）预计2026年1-6月归属净利润盈利1.4亿元至1.6亿元
证券之星 · 07-16
股市必读：建发致新（301584）预计2026年1-6月归属净利润盈利1.4亿元至1.6亿元
建发致新：预计2026年1-6月扣非后净利润盈利1.4亿元至1.6亿元
证券之星 · 07-15
建发致新：预计2026年1-6月扣非后净利润盈利1.4亿元至1.6亿元
建发致新（301584）披露2026年半年度业绩预告，7月15日股价下跌0.73%
证券之星 · 07-15
建发致新（301584）披露2026年半年度业绩预告，7月15日股价下跌0.73%
建发致新(301584.SZ)发预增，预计上半年归母净利润1.4亿元至1.6亿元，同比增长2.16%至16.76%
智通财经 · 07-15
建发致新(301584.SZ)发预增，预计上半年归母净利润1.4亿元至1.6亿元，同比增长2.16%至16.76%
建发致新（301584）披露拟注册发行银行间债券市场非金融企业债务融资工具议案，7月14日股价上涨13.74%
证券之星 · 07-14
建发致新（301584）披露拟注册发行银行间债券市场非金融企业债务融资工具议案，7月14日股价上涨13.74%
建发致新最新公告：拟收购建发致瑞100%股权
证券之星 · 07-08
建发致新最新公告：拟收购建发致瑞100%股权
建发致新(301584)6月18日股东户数1.73万户，较上期增加1.53%
证券之星 · 06-29
建发致新(301584)6月18日股东户数1.73万户，较上期增加1.53%
建发致新：截止最近一次查询日2026年6月18日，公司股东数量为17,305名
证券之星 · 06-29
建发致新：截止最近一次查询日2026年6月18日，公司股东数量为17,305名
暂无数据
公司概况
公司名称：
上海建发致新医疗科技集团股份有限公司
所属行业：
批发业
上市日期：
2025-09-25
主营业务：
上海建发致新医疗科技集团股份有限公司的主营业务是医疗器械直销及分销业务，并为终端医疗机构提供医用耗材集约化运营与供应（SPD）等服务。公司的主要产品是血管介入器械、外科器械、IVD（体外诊断）、医疗设备。
发行价格：
7.05
{"stockData":{"symbol":"301584","market":"SZ","secType":"STK","nameCN":"建发致新","latestPrice":21.5,"timestamp":1787721810000,"preClose":21.77,"halted":0,"volume":1366734,"delay":0,"changeRate":-0.0124,"floatShares":53714300,"shares":421000000,"eps":0.666,"marketStatus":"交易中","change":-0.27,"latestTime":"08-26 13:23:30","open":21.74,"high":21.98,"low":21.47,"amount":29609200,"amplitude":0.0234,"askPrice":21.5,"askSize":11,"bidPrice":21.49,"bidSize":129,"shortable":0,"etf":0,"ttmEps":0.666,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1787727600000},"marketStatusCode":2,"adr":0,"adjPreClose":21.77,"symbolType":"stock","openAndCloseTimeList":[[1787707800000,1787715000000],[1787720400000,1787727600000]],"highLimit":23.95,"lowLimit":19.59,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":421288509,"isCdr":false,"pbRate":4.23,"roa":"--","peRate":32.282282,"roe":"6.82%","epsLYR":0.72,"committee":0.314528,"marketValue":9058000000,"turnoverRate":0.0254,"status":1,"floatMarketCap":1155000000},"requestUrl":"/m/hq/s/301584/tweets","defaultTab":"tweets","newsList":[{"id":"2661253035","title":"建发致新：长城证券、国泰海通证券等多家机构于8月20日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2661253035","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661253035?lang=zh_cn&edition=full","pubTime":"2026-08-21 08:43","pubTimestamp":1787273026,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月20日建发致新发布公告称长城证券、国泰海通证券、金浦健服、光大证券资管、东方证券资管、国联安基金、巨创私募于2026年8月20日调研我司。SPD业务驻场运营人员则相对固定，负责订单处理、供应商资质审核、物流管理、财务结算等日常运营工作。根据《中国公立医院医疗器械 SPD行业发展报告 2025》数据，国药控股市场份额超过20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100008617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02611","BK0250","BK0012","BK0188","BK1564","601211","BK0201","301584","BK1147","161027","BK0276","BK0028","BK0183","BK0184","002939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437479","title":"建发致新（301584）2026年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437479","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660437479?lang=zh_cn&edition=full","pubTime":"2026-08-18 06:02","pubTimestamp":1787004156,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期建发致新发布2026年中报。截至本报告期末，公司营业总收入100.04亿元，同比上升1.79%，归母净利润1.48亿元，同比上升7.98%。按单季度数据看，第二季度营业总收入54.82亿元，同比上升3.17%，第二季度归母净利润8279.85万元，同比下降5.72%。本报告期建发致新盈利能力上升，毛利率同比增幅2.16%，净利率同比增幅10.59%。所得税费用变动幅度为36.13%,原因:业务规模增长带来的利润增长及税费事项调整等因素综合影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800004156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487384","title":"建发致新2026年半年报：营收微增，高应收、行业低毛利风险待解","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487384","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660487384?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:57","pubTimestamp":1786967874,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月17日讯，8月16日，建发致新发布 2026 年半年度报告。医疗器械流通行业整体增速放缓，院内 SPD 供应链业务持续渗透，公司营收小幅增长，利润增速跑赢收入，应收账款回款改善，经营现金流实现扭亏修复。传统器械分销行业内卷严重，整体营收增速有限；SPD 院内供应链业务持续拓展，供应链精细化管理能力提升。后续重点跟踪 SPD 业务扩张速度、应收账款周转、毛利率改善，投资者应当充分认知流通行业薄利运营的行业特征。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1786962879571737593","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["301584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659177594","title":"建发致新：公司无逾期担保的情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2659177594","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659177594?lang=zh_cn&edition=full","pubTime":"2026-08-16 20:34","pubTimestamp":1786883640,"startTime":"0","endTime":"0","summary":"证券日报网讯 8月16日，建发致新发布公告称，公司及控股子公司未对合并报表外单位提供担保。公司无逾期担保的情形，不存在涉及诉讼的担保及因担保被判决败诉而应承担损失等情形。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-16/doc-ininpmth0857409.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-16/doc-ininpmth0857409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301584","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659174251","title":"图解建发致新中报：第二季度单季净利润同比下降5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659174251","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659174251?lang=zh_cn&edition=full","pubTime":"2026-08-16 17:13","pubTimestamp":1786871585,"startTime":"0","endTime":"0","summary":"证券之星消息，建发致新2026年中报显示，上半年度公司主营收入100.04亿元，同比上升1.79%；归母净利润1.48亿元，同比上升7.98%；扣非净利润1.48亿元，同比上升8.6%；其中2026年第二季度，公司单季度主营收入54.82亿元，同比上升3.17%；单季度归母净利润8279.85万元，同比下降5.72%；单季度扣非净利润8500.39万元，同比下降3.2%；负债率84.58%，投资收益-534.33万元，财务费用4703.8万元，毛利率8.1%。财报数据概要请见下图:本文数据来源于建发致新2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600006200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659174473","title":"建发致新(301584)8月10日股东户数1.9万户，较上期增加9.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659174473","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659174473?lang=zh_cn&edition=full","pubTime":"2026-08-16 17:04","pubTimestamp":1786871064,"startTime":"0","endTime":"0","summary":"证券之星消息，近日建发致新披露，截至2026年8月10日公司股东户数为1.9万户，较6月18日增加1667.0户，增幅为9.63%。在医药商业行业个股中，建发致新股东户数低于行业平均水平，截至8月10日，医药商业行业平均股东户数为4.72万户。从股价来看，2026年6月18日至2026年8月10日，建发致新区间涨幅为10.23%，在此期间股东户数增加1667.0户，增幅为9.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600005869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659174194","title":"建发致新(301584.SZ)：上半年净利润1.48亿元 同比增长7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659174194","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659174194?lang=zh_cn&edition=full","pubTime":"2026-08-16 16:27","pubTimestamp":1786868821,"startTime":"0","endTime":"0","summary":"格隆汇8月16日丨建发致新发布2026年半年度报告，报告期内，公司积极适应市场变化，坚持围绕医疗器械流通领域提升运营管理能力和服务水平，2026年上半年实现合并营业收入100.04亿元，同比增长1.79%，整体经营规模保持稳定；实现归属于上市公司股东的净利润1.48亿元，同比增长7.98%，受分销及SPD业务增长、财务费用下降以及资产减值损失同比减少等因素综合影响，整体盈利能力有所提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260816/32336290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659721301","title":"建发致新拟每10股派发现金股利1元","url":"https://stock-news.laohu8.com/highlight/detail?id=2659721301","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659721301?lang=zh_cn&edition=full","pubTime":"2026-08-16 16:17","pubTimestamp":1786868220,"startTime":"0","endTime":"0","summary":"8月16日，建发致新（301584）发布公告，公司拟向全体股东每10股派发现金股利1元（含税），预计总派发金额为4213万元，占归母净利润的28.47%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2026-08-16/doc-ininnzcq9757927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","VIG","BK4588","BK4585","301584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659174606","title":"建发致新最新公告：2026年半年度净利润1.48亿元同比增长7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659174606","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659174606?lang=zh_cn&edition=full","pubTime":"2026-08-16 15:50","pubTimestamp":1786866606,"startTime":"0","endTime":"0","summary":"建发致新(301584.SZ)公告称，公司发布2026年半年度报告，实现营业收入100.04亿元，同比增长1.79%；归属于上市公司股东的净利润1.48亿元，同比增长7.98%。业绩增长主要系分销及SPD业务增长、财务费用下降以及资产减值损失同比减少等因素综合影响。公司拟向全体股东每10股派发现金红利1元(含税)。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600002248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659112166","title":"建发致新：截止最近一次查询日2026年8月10日，公司股东数量为18,972名","url":"https://stock-news.laohu8.com/highlight/detail?id=2659112166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659112166?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:00","pubTimestamp":1786698046,"startTime":"0","endTime":"0","summary":"证券之星消息，建发致新(301584)08月14日在投资者关系平台上答复投资者关心的问题。投资者提问：你好 请问截止目前 最新股东人数是多少建发致新回复：你好，尊敬的投资者，截止最近一次查询日2026年8月10日，公司股东数量为18,972名。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400027917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658904932","title":"建发致新（301584）披露为下属子公司提供担保的进展公告，8月10日股价上涨2.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658904932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658904932?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:22","pubTimestamp":1786371737,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，建发致新报收于23.6元，较前一交易日上涨2.52%，最新总市值为99.42亿元。该股当日开盘23.03元，最高24.81元，最低23.03元，成交额达2.42亿元，换手率为18.81%。公司于近日披露《关于为下属子公司提供担保的进展公告》。本次担保属于公司2026年度预计担保额度范围内的事项，无需另行履行审议程序。公司未对合并报表外单位提供担保，无逾期担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000034196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655076048","title":"股市必读：建发致新（301584）新发布《2026年第三次临时股东会决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2655076048","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655076048?lang=zh_cn&edition=full","pubTime":"2026-07-31 01:39","pubTimestamp":1785433150,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年第三次临时股东会审议通过《关于拟注册发行银行间债券市场非金融企业债务融资工具的议案》，同意比例达99.9299%。北京国枫律师事务所关于上海建发致新医疗科技集团股份有限公司2026年第三次临时股东会的法律意见书北京国枫律师事务所就本次临时股东会的召集与召开程序、召集人资格、出席会议人员资格、表决程序及表决结果出具法律意见书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651495625","title":"股市必读：建发致新（301584）预计2026年1-6月归属净利润盈利1.4亿元至1.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651495625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651495625?lang=zh_cn&edition=full","pubTime":"2026-07-16 04:00","pubTimestamp":1784145642,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，建发致新报收于24.32元，下跌0.73%，换手率28.21%，成交量15.15万手，成交额3.75亿元。2026年半年度业绩预告上海建发致新医疗科技集团股份有限公司预计2026年上半年归属于上市公司股东的净利润为14,000万元至16,000万元，同比增长2.16%至16.76%；扣除非经常性损益后的净利润为14,000万元至16,000万元，同比增长2.63%至17.30%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600004419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651789451","title":"建发致新：预计2026年1-6月扣非后净利润盈利1.4亿元至1.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651789451","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651789451?lang=zh_cn&edition=full","pubTime":"2026-07-15 18:01","pubTimestamp":1784109676,"startTime":"0","endTime":"0","summary":"证券之星消息，建发致新发布业绩预告，预计2026年1-6月扣非后净利润盈利1.4亿元至1.6亿元。建发致新2026年一季报显示，一季度公司主营收入45.23亿元，同比上升0.15%；归母净利润6517.85万元，同比上升32.44%；扣非净利润6312.94万元，同比上升29.91%；负债率83.38%，投资收益-249.11万元，财务费用2271.57万元，毛利率8.04%。本文数据来源于《建发致新:2026年半年度业绩预告》，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500036226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651511074","title":"建发致新（301584）披露2026年半年度业绩预告，7月15日股价下跌0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651511074","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651511074?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:58","pubTimestamp":1784109501,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，建发致新报收于24.32元，较前一交易日下跌0.73%，最新总市值为102.46亿元。该股当日开盘23.5元，最高26.47元，最低23.0元，成交额达3.75亿元，换手率为28.21%。公司于2026年7月15日披露《2026年半年度业绩预告》，预计2026年上半年归属于上市公司股东的净利润为14,000万元至16,000万元，同比增长2.16%至16.76%；扣除非经常性损益后的净利润为14,000万元至16,000万元，同比增长2.63%至17.30%。本次业绩预告未经会计师事务所预沟通，具体数据以2026年半年度报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500035614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651453359","title":"建发致新(301584.SZ)发预增，预计上半年归母净利润1.4亿元至1.6亿元，同比增长2.16%至16.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651453359","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651453359?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:13","pubTimestamp":1784103192,"startTime":"0","endTime":"0","summary":"智通财经APP讯，建发致新(301584.SZ)发布公告，公司预计2026年上半年归属于上市公司股东的净利润为1.4亿元至1.6亿元，同比增长2.16%至16.76%。报告期内，公司积极应对市场变化，持续推进业务结构优化和市场拓展，分销业务及医用耗材集约化运营(SPD)业务保持较快发展，带动公司整体毛利水平同比增加。受资产质量变化及存货减值因素影响，公司资产减值损失较上年同期减少，进一步改善了公司盈利水平。同时，公司持续加强资金管理，融资成本同比下降，财务费用较上年同期减少。另一方面，随着业务规模变化及税费因素影响，公司税金及附加、所得税费用较上年同期有所增加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651104801","title":"建发致新（301584）披露拟注册发行银行间债券市场非金融企业债务融资工具议案，7月14日股价上涨13.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651104801","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651104801?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:18","pubTimestamp":1784038697,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，建发致新报收于24.5元，较前一交易日上涨13.74%，最新总市值为103.22亿元。该股当日开盘21.33元，最高24.73元，最低21.0元，成交额达3.4亿元，换手率为26.83%。公告显示，公司将于2026年7月30日召开2026年第三次临时股东会，股权登记日为2026年7月27日，会议将审议《关于拟注册发行银行间债券市场非金融企业债务融资工具的议案》。股东可通过现场或网络投票方式参与表决，网络投票通过深圳证券交易所系统和互联网投票系统进行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649999317","title":"建发致新最新公告：拟收购建发致瑞100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2649999317","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649999317?lang=zh_cn&edition=full","pubTime":"2026-07-08 19:50","pubTimestamp":1783511433,"startTime":"0","endTime":"0","summary":"建发致新(301584.SZ)公告称，公司拟以自有资金收购控股股东建发医疗及弘园医疗持有的建发致瑞100%股权，交易对价3506.68万元。收购完成后，建发致瑞将纳入公司合并报表范围，旨在向医疗产业链上游流通服务延伸布局。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800038594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647320603","title":"建发致新(301584)6月18日股东户数1.73万户，较上期增加1.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647320603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647320603?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:43","pubTimestamp":1782726197,"startTime":"0","endTime":"0","summary":"证券之星消息，近日建发致新披露，截至2026年6月18日公司股东户数为1.73万户，较5月20日增加260.0户，增幅为1.53%。在医药商业行业个股中，建发致新股东户数低于行业平均水平，截至6月18日，医药商业行业平均股东户数为4.74万户。从股价来看，2026年5月20日至2026年6月18日，建发致新区间跌幅为12.31%，在此期间股东户数增加260.0户，增幅为1.53%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900027362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647326772","title":"建发致新：截止最近一次查询日2026年6月18日，公司股东数量为17,305名","url":"https://stock-news.laohu8.com/highlight/detail?id=2647326772","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647326772?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:06","pubTimestamp":1782716790,"startTime":"0","endTime":"0","summary":"证券之星消息，建发致新(301584)06月29日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司最新股东人数建发致新回复：你好，尊敬的投资者，截止最近一次查询日2026年6月18日，公司股东数量为17,305名。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900016752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301584","BK0250"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787721812281,"stockEarnings":[{"period":"1week","weight":-0.0807},{"period":"1month","weight":0.0831},{"period":"3month","weight":-0.0414},{"period":"6month","weight":-0.2416},{"period":"1year","weight":2.0879},{"period":"ytd","weight":-0.2484}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":0.0197},{"period":"3month","weight":-0.0499},{"period":"6month","weight":-0.062},{"period":"1year","weight":0.0015},{"period":"ytd","weight":-0.02}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海建发致新医疗科技集团股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"18972人(较上一季度增加11.86%)","perCapita":"2831股","listingDate":"2025-09-25","address":"上海市杨浦区杨树浦路288号9层","registeredCapital":"42128万元","survey":" 上海建发致新医疗科技集团股份有限公司的主营业务是医疗器械直销及分销业务，并为终端医疗机构提供医用耗材集约化运营与供应（SPD）等服务。公司的主要产品是血管介入器械、外科器械、IVD（体外诊断）、医疗设备。","listedPrice":7.05},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"建发致新(301584)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供建发致新(301584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"建发致新,301584,建发致新股票,建发致新股票老虎,建发致新股票老虎国际,建发致新行情,建发致新股票行情,建发致新股价,建发致新股市,建发致新股票价格,建发致新股票交易,建发致新股票购买,建发致新股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"建发致新(301584)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供建发致新(301584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}